SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001437749-18-000555
Filing Date
2018-01-12
Accepted
2018-01-12 06:30:35
Documents
16

Document Format Files

Seq Description Document Type Size
1 FORM 8-K avir20180111_8k.htm 425 33555
2 EXHIBIT 99.1 ex_102927.htm EX-99.1 32521
3 EXHIBIT 99.2 ex_102928.htm EX-99.2 8863
4 a12.jpg GRAPHIC 121007
5 a11.jpg GRAPHIC 144154
6 a10.jpg GRAPHIC 151060
7 a09.jpg GRAPHIC 171526
8 a08.jpg GRAPHIC 173198
9 a07.jpg GRAPHIC 123233
10 a06.jpg GRAPHIC 139310
11 a05.jpg GRAPHIC 156807
12 a04.jpg GRAPHIC 176685
13 a03.jpg GRAPHIC 202070
14 a02.jpg GRAPHIC 271416
15 a01.jpg GRAPHIC 73053
16 logo.jpg GRAPHIC 9036
  Complete submission text file 0001437749-18-000555.txt   2712310
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Filed by) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 425 | Act: 34 | File No.: 001-35285 | Film No.: 18524659
SIC: 2836 Biological Products, (No Diagnostic Substances)